On stage

Upcoming Events

December 6, 2019

16th Global Cardiovascular Clinical Trialists Forum

Real-world data to predict randomized trial results before they’re done: The RCT DUPLICATE initiative
Jeremy Rassen
December 6, 2019

16th Global Cardiovascular Clinical Trialists Forum

Data provenance and protection with real-world data, practical aspects of implementing credible real-world evidence: Industry perspective
Carolyn Magill
December 9, 2019

Longwood Annual Healthcare Leaders Meeting

Getting to drug approval
Carolyn Magill
December 10, 2019

Digital Healthcare Innovation Summit

Building a strong case with real-world evidence
Carolyn Magill
January 14, 2020

J.P. Morgan 38th Healthcare Conference

WuXi Global Forum
Carolyn Magill

Past Events

November 15, 2019

DIA Real World Evidence Conference

What's next: Real-world evidence in the development and access of novel therapeutics
Jeremy Rassen
November 12, 2019

Friends of Cancer Research Annual Meeting

Characterizing the use of external controls for augmenting randomized control arms and confirming benefit
Jeremy Rassen
November 6, 2019

ISPOR Europe 2019

Big healthcare data — Endless opportunities for research and learning
Jeremy Rassen
November 5, 2019

ISPOR Europe 2019

Are value assessment frameworks using RWE? A review of NICE and ICER psoriasis assessments
Ashley Jaksa
November 4, 2019

ISPOR Europe 2019

Are we there yet? Using RWD for regulatory-grade external control arms
Jeremy Rassen & Yin Ho
November 4, 2019

ISPOR Europe 2019

Themes in the design of pharmaceutical value-based contracts in the United States and Europe
Andrew Weckstein
November 4, 2019

ISPOR Europe 2019

Transparency in RWE — Time for a unified approach
Sebastian Schneeweiss
November 2, 2019

ISPOR Europe 2019

Use of propensity scores in observational studies of treatment effects
Jeremy Rassen
October 31, 2019

AMCP Nexus 2019

Using real-world evidence to design value-based contracts for the real world
Amanda Patrick
October 30, 2019

HLTH - The Future of Healthcare

The 7 things smart companies do to close the gender gap
Carolyn Magill
October 28, 2019

HLTH - The Future of Healthcare

Real-world evidence for value-based care
Carolyn Magill
October 24, 2019

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

Panel discussion: Pros & cons of real-world evidence framework by FDA. Perspective from different stakeholders — providers & payers
Kristen Coletto
October 18, 2019

2019 Wharton Health Care Conference on Artificial Intelligence

Real-world evidence case study
Carolyn Magill
October 16, 2019

Connected Health Conference

How real-world evidence will facilitate the shift toward value-based care
Wendy Turenne
October 11, 2019

ISPOR Summit 2019

Transparency in RWE — Time for a unified approach
Sebastian Schneeweiss
October 3, 2019

Duke-Margolis: Developing Real-World Data and Evidence to Support Regulatory Decision-Making

Methodological and analytical considerations for observational studies
Sebastian Schneeweiss
October 2, 2019

Future of Health

Digital Health 150
Jeremy Rassen
September 18, 2019

IMPACCT: RWE

Real-world evidence to support regulatory submissions
Sebastian Schneeweiss
September 18, 2019

Friends of Cancer Research 8th Annual Blueprint for Breakthrough Forum

The future of real-world evidence: Informing regulatory and payer decisions
Jeremy Rassen
September 17, 2019

Health 2.0

The keys to outcome and evidence-based care
Carolyn Magill
August 26, 2019

35th ICPE

Poster, podium, and symposia presentations
Jeremy Rassen, Sebastian Schneeweiss, Sruthi Adimadhyam, Elizabeth Dabrowski, Liz Garry, Amanda Patrick, Natalia Petruski-Ivleva, and Dana Teltsch
July 23, 2019

eyeforpharma Webinar

The real-world evidence regulatory evolution: How to use RWE to augment RCTs and advance the drug development paradigm
Jeremy Rassen & Sebastian Schneeweiss
June 25, 2019

DIA Global Annual Meeting

Use of real-world evidence to support regulatory decision-making: First-year findings from the RCT-DUPLICATE project
Jeremy Rassen
June 24, 2019

DIA Global Annual Meeting

Using real-world data to develop a safety monitoring program and ensure pre- and post-market continuity
Jeremy Rassen
June 11, 2019

5th Annual d.health Summit: Aging Americans Innovation Conference

Facilitated discussion
Carolyn Magill
June 7, 2019

American Diabetes Association

RWD analyses for regulatory decision-making
Sebastian Schneeweiss
June 3, 2019

BIO 2019

Real-world data external controls panel
Jeremy Rassen
May 22, 2019

ISPOR 2019

Replicable and robust database evidence: What does it look like?
Jeremy Rassen
May 22, 2019

ISPOR 2019

Quantifying the opportunity to reduce total cost of care through targeted medication prioritization and adherence improvement in diabetes
Sara Eapen, Jeremy Rassen & Sebastian Schneeweiss
May 20, 2019

ISPOR 2019

Replication of randomized controlled trials using real-world data: What does good look like?
Sebastian Schneeweiss
May 18, 2019

ISPOR 2019

Use of propensity scores in observational studies of treatment effects
Jeremy Rassen
May 18, 2019

ISPOR 2019

De-Risking Risk Sharing: Enabling Payer-Pharma Interactions and Value-based Contracting with RWE
Jeremy Rassen & Sebastian Schneeweiss
April 29, 2019

2019 Blue Cross Blue Shield National Summit

Applying rapid-cycle analytics of real-wolrd data to reduce medical costs and improve outcomes among high-risk members: case studies in diabetes and inflammatory bowel disease
Sara Eapen & Sebastian Schneeweiss
April 24, 2019

12th Annual FDA/AdvaMed Medical Devices & Diagnostics Statistical Issues Conference

An approach for incorporating real-world evidence into regulatory decision-making
Priscilla Velentgas
April 17, 2019

eyeforpharma Philadelphia

Panel: A strategic cross-functional approach to evidence generation
Scott Musial
April 10, 2019

Health Evolution Summit

Corporate Venture Group panel
Carolyn Magill
April 9, 2019

Danish Epidemiological Society Spring Meeting 2019

Automated data adaptive analytics for electronic healthcare data to study causal treatment effects
Sebastian Schneeweiss
April 6, 2019

ISPE's 2019 Mid-Year Meeting

Scientific perspectives on biologic and biosimilar use
Sebastian Schneeweiss
April 3, 2019

FORTUNE Brainstorm Health 2019

Lunch session
Carolyn Magill
April 2, 2019

Harvard-MIT CRS Regulatory Science Symposium 2019

Real-world evidence sessions
Jeremy Rassen & Sebastian Schneeweiss
April 2, 2019

Healthcare Costs Innovation Summit

The value-based care movement
Carolyn Magill
March 28, 2019

2019 Health Datapalooza

Rapid fire: Real world evidence
Carolyn Magill
March 25, 2019

AMCP Managed Care & Specialty Pharmacy Annual Meeting

Using rapid-cycle analytics of real-world data to manage high risk, high cost patients
Sara Eapen & Sebastian Schneeweiss
March 21, 2019

International Society for Pharmacoepidemiology (ISPE) Webinar

Visual pharmacoepidemiology
Jeremy Rassen
March 20, 2019

Pharmaceutical Executive Webinar

Using real-world evidence for U.S. regulatory decision-making: What pharma needs to know
Carolyn Magill & Sebastian Schneeweiss
March 12, 2019

RWE Europe at eyeforpharma Barcelona

Understand the acceptability of RWE across global regulatory decision-making
Jeremy Rassen
February 6, 2019

DIA Europe 2019

Confidence in real world data
Sebastian Schneeweiss
February 4, 2019

National Health Policy Conference

Future directions in regulatory policy: the role of real-world evidence
Jeremy Rassen
January 29, 2019

DIA's Pharmacovigilance and Risk Management Strategies Conference

When and how can RWD analyses support regulator decision making
Sebastian Schneeweiss
January 22, 2019

Duke-Margolis Center for Health Policy

Unpacking real-world data curation: Principles and best practices to support transparency and quality
Jeremy Rassen
January 17, 2019

International Society for Pharmacoepidemiology (ISPE) Webinar

A decade of experience with high-dimensional propensity scores
Sebastian Schneeweiss
January 16, 2019

Symposium on Accessibility and Impact of High Value Medicines

Evidences of access impact: Conclusions from the satellite workshop
Sebastian Schneeweiss
January 15, 2019

Symposium on Accessibility and Impact of High Value Medicines

How can observational studies reproduce causality assessment
Sebastian Schneeweiss
January 7, 2019

37th Annual J.P. Morgan Healthcare Conference

Digital health panel
Carolyn Magill

The Evidence Digest

Subscribe to our newsletter for insights and updates on real-world evidence research and applications.
Thank you, you've been subscribed.
Oops! Something went wrong while submitting the form.
©2018 Aetion, Inc.      Terms of Use      Privacy Policy      Patents